fluorodeoxyglucose f18 has been researched along with Uremia in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brown, J; Dilsizian, V; Dinits-Pensy, MY; Fink, JC; Hinduja, A; Lodge, MA; Smith, MF | 1 |
Hsu, JL; Shen, YY; Wang, HC | 1 |
Chen, YK; Kao, CH; Leu, JG | 1 |
3 other study(ies) available for fluorodeoxyglucose f18 and Uremia
Article | Year |
---|---|
Pre-clinical myocardial metabolic alterations in chronic kidney disease.
Topics: Adult; Biomarkers; Cardiovascular Diseases; Chronic Disease; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; Glomerular Filtration Rate; Humans; Kidney Diseases; Male; Middle Aged; Myocardium; Pilot Projects; Positron-Emission Tomography; Uremia; Young Adult | 2010 |
Acute bilateral basal ganglia lesions in patients with diabetic uremia: an FDG-PET study.
Topics: Acute Disease; Aged; Basal Ganglia; Basal Ganglia Diseases; Diabetic Nephropathies; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed; Uremia | 2004 |
Renal transitional cell carcinoma diagnosed by FDG-PET in a uremic kidney.
Topics: Adult; Carcinoma, Transitional Cell; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Uremia | 2006 |